Pharsight

Perjeta patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US7862817 NA Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
Jun, 2025

(1 year, 7 months from now)

Ingredients: PERTUZUMAB

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic